SeaStar Medical Holding Corporation Common Stock (ICU) is a publicly traded Healthcare sector company. As of May 21, 2026, ICU trades at $4.02 with a market cap of $15.99M and a P/E ratio of -0.67. ICU moved +1.54% today. Year to date, ICU is +53.28%; over the trailing twelve months it is -69.11%. Its 52-week range spans $2.07 to $44.90. Analyst consensus is buy with an average price target of $8.00. Rallies surfaces ICU's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
SeaStar Medical Secures $23.9M Funding, Hits 50% Enrollment in AKI Trial: SeaStar Medical added 13 pediatric hospital customers, raising its QUELIMMUNE base to 16, secured $23.9 million in capital, and cut $3.1 million in liabilities. It enrolled 181 of 339 patients (over 50%) in its NEUTRALIZE-AKI trial and projects roughly $2 million in net product revenue for 2026.
| Metric | Value |
|---|---|
| Price | $4.02 |
| Market Cap | $15.99M |
| P/E Ratio | -0.67 |
| EPS | $-5.86 |
| Dividend Yield | 0.00% |
| 52-Week High | $44.90 |
| 52-Week Low | $2.07 |
| Volume | 56 |
| Avg Volume | 0 |
| Revenue (TTM) | $1.23M |
| Net Income | $-12.15M |
| Gross Margin | 95.70% |
1 analysts cover ICU: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $8.00.